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Abstract
Background: In functional genomics studies, tests on mean heterogeneity have been widely employed to identify
differentially expressed genes with distinct mean expression levels under different experimental conditions. Variance
heterogeneity (aka, the difference between condition-specific variances) of gene expression levels is simply
neglected or calibrated for as an impediment. The mean heterogeneity in the expression level of a gene reflects
one aspect of its distribution alteration; and variance heterogeneity induced by condition change may reflect
another aspect. Change in condition may alter both mean and some higher-order characteristics of the
distributions of expression levels of susceptible genes.
Results: In this report, we put forth a conception of mean-variance differentially expressed (MVDE) genes, whose
expression means and variances are sensitive to the change in experimental condition. We mathematically proved
the null independence of existent mean heterogeneity tests and variance heterogeneity tests. Based on the
independence, we proposed an integrative mean-variance test (IMVT) to combine gene-wise mean heterogeneity
and variance heterogeneity induced by condition change. The IMVT outperformed its competitors under
comprehensive simulations of normality and Laplace settings. For moderate samples, the IMVT well controlled type
I error rates, and so did existent mean heterogeneity test (i.e., the Welch t test (WT), the moderated Welch t test
(MWT)) and the procedure of separate tests on mean and variance heterogeneities (SMVT), but the likelihood ratio
test (LRT) severely inflated type I error rates. In presence of variance heterogeneity, the IMVT appeared noticeably
more powerful than all the valid mean heterogeneity tests. Application to the gene profiles of peripheral circulating
B raised solid evidence of informative variance heterogeneity. After adjusting for background data structure, the
IMVT replicated previous discoveries and identified novel experiment-wide significant MVDE genes.
Conclusions: Our results indicate tremendous potential gain of integrating informative variance heterogeneity after
adjusting for global confounders and background data structure. The proposed informative integration test better
summarizes the impacts of condition change on expression distributions of susceptible genes than do the existent
competitors. Therefore, particular attention should be paid to explicitly exploit the variance heterogeneity induced
by condition change in functional genomics analysis.
Keywords: Functional genomics studies, MVDE genes, Integrative heterogeneity test, Latent confounders, Latent
biomarkers
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Background
Typically, comparative microarray experiments analyze
expressions of thousands to tens of thousands of genes.
A core challenge is to identify statistically significant
genes of biologically meaningful changes in expression
levels under different conditions. Differentially expressed
genes may help identify disease biomarkers that are im-
portant for the diagnosis of multiple diseases [1, 2].
There are several existent mean heterogeneity tests for
identifying differentially expressed genes. The Student t
test (ST) has been widely applied as a standard routine
for identifying mean differentially expressed (MDE)
genes in two-condition experiments [3]. The null hy-
pothesis of this test is mean homogeneity H01: the test-
ing gene has identical mean expression level under the
two conditions. It assumes variance homogeneity H02:
the testing gene has identical variance in expression level
under the two conditions. The necessity of H02 for the
ST was formally examined under normality setting [4].
It tends to inflate type I error rate for rejecting mean
equality if the smaller sample is from the population
with the larger variance. In contrast, it tends to be con-
servative if the larger sample is from the population with
smaller variance. The WT [5] is an adaptation of the ST
to allow for potential variance heterogeneity between
two experimental conditions. This test calibrates poten-
tial variance heterogeneity as an impediment to identify
differentially expressed genes. Demissie et al. developed
the MWT [6] to obtain more stable estimates of the
error variance of a gene in a low-replicate microarray
experiment. The MWT outperformed the Welch test to
allow for variance heterogeneity. All aforesaid tests ei-
ther simply ignore or take the variance heterogeneity as
an impediment and calibrate it when identifying differ-
entially expressed genes.
In comparative microarray experiments, condition
change may alter entire expression distributions of suscep-
tible genes. Genes can interact with each other and inter-
act with environmental factors. For a gene in a complex
network, its distribution heterogeneity of expression levels
can include heterogeneities in mean, variance, and even
higher-order mathematical characteristics. Thus far, re-
searchers have been conventionally focusing on exploiting
mean heterogeneity, simply ignoring or adjusting for over-
all intra-condition variance heterogeneity. Herein, we dis-
tinguish ‘informative component’ from ‘impediment
component’ of the overall variance heterogeneity. Specific-
ally, we call the variance heterogeneity due to condition
change as ‘informative variance heterogeneity’; and call
variance heterogeneity due to environmental covariates
and latent factors (i.e., background data structure) as
impediment variance heterogeneity. However, inform-
ative variance heterogeneity has not been well recog-
nized and exploited.
Informative variance heterogeneity of a susceptible
gene can capture extra information conveyed by compli-
cated biological networks. High gene-gene correlations
are common in co-expression networks of differentially
expressed genes [7, 8]. Genes can interact with each
other and/or interact with environmental factors. There-
fore, the alteration of expression distribution of a suscep-
tible gene cannot be completely determined by its mean
heterogeneity. Heterogeneities of high-order characteris-
tics, e.g., variance and kurtosis, can provide extra valuable
information. Exploiting informative mean heterogeneity of
gene expression level alone would be incompetent to ex-
tract the information of the second-order moment (i.e.,
the variance). In context of genetic association studies,
there are existent methods for integrating variance hetero-
geneity to identify genetic loci which are associated with
the variances of quantitative traits (vQTL) [9, 10] and
gene expression levels (evQTL) [11]. In addition, KA
Geiler-Samerotte [12] presented several biological exam-
ples and also argued that variance heterogeneities of
biological data may provide insight about phenotypic
variability. Detecting QTLs, however, is different from
detecting differential expressions between comparative
microarray experiments. Existent methods cannot expli-
citly integrate the informative variance heterogeneity of
gene expressions due to condition change; and little has
been done to distill informative variance heterogeneity.
In this article, we put forth mean-variance differen-
tially expressed (MVDE) gene as a novel concept. The
family of MVDE genes is broader than that of conven-
tional MDE genes. It goes one step closer to our generic
concept of a susceptible gene − a gene displays reliable
changes in any aspects of the entire distribution of its
expression level with the change in condition. A MVDE
gene may display different means and/or variances of ex-
pression levels between two different conditions. The
proper null hypothesis of testing MVDE is H03 =H01 ∩
H02: the gene has equal mean and equal variance of ex-
pression levels between the two conditions. We reject
the dual null hypothesis (H03) and claim the testing gene
if the data raises significant evidence for mean hetero-
geneity, variance heterogeneity, or both. Under normal-
ity setting, the two-sample F-test is the most powerful
procedure for exploiting variance heterogeneity. But the
F-test is very sensitive to the violation of normality [13].
Beyond normality setting, the Levene test [14] and the
Brown–Forsythe test [15] are two popular alternatives
for inspecting variance heterogeneity.
We mathematically proved and empirically illustrated
that testing statistics of mean heterogeneity and variance
heterogeneity are independently distributed under H03.
This null independence is not well-known to many, but
is crucial to assure the type I error rate control of the
IMVT using Fisher’s method [15]. Under comprehensive
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simulations, the IMVT appeared noticeably more powerful
than existent mean heterogeneity tests (i.e., WT, MWTand
STSD) as well as the LRT and the SMVT for identifying
MVDE genes. In particular, the IMVT appeared strikingly
more powerful than the mean heterogeneity tests to iden-
tify genes with variance heterogeneity. To illustrate the
practical utility of our IMVT, we reanalyzed the gene pro-
files of peripheral circulating B cells [16] after adjusting for
global confounders and background data structure. Our
IMVT replicated previous discoveries and identified novel
genes that were missed by existent mean heterogeneity
tests. Our results highlighted the importance of exploiting
informative variance heterogeneity, which is a rich resource
about the biology mechanism of gene expressions.
Methods
Let the dataset contain expression levels of M gene probes
of nc unrelated subjects from condition c (i.e., c = 1 for
control group, and c = 2 for treatment group). To be spe-
cific, let Gijc be the expression level of gene probe i
(=1,2,…,M) on subject j (=1,2,…,nc) under condition c, and
let n = n1 + n2 be the total sample size. Let μic and σic
2 be
the gene-specific mean and variance of the expression
levels of gene probe i under condition c, respectively. The
standard unbiased estimators of μic and σic
2 are given by
μ^ic ¼ Gic ¼
Xnc
j¼1Gijc=nc and σ^
2
ic ¼
Xnc
j¼1 Gijc−Gic
 2
=
nc−1ð Þ, respectively.
Concept of MDE genes and mean heterogeneity tests
Researchers conventionally focus on identifying MDE
genes. A MDE gene displays mean differentials between
the expression levels under two experimental conditions
(μ1 ≠ μ2). The ST has been widely used routine to
identify MDE genes. This mean heterogeneity test re-
jects the null hypothesis H01 : μ1 = μ2 if the Student
statistic of the testing gene departures from zero sig-
nificantly. A default assumption behind the ST is vari-
ance equality H02 : σ1
2 = σ2
2 at the testing gene. Specifically,
for the ith gene, let G1 ¼ Gi11; ;Gi21;…; ;Gin11ð Þ′ and
G2 ¼ Gi12; ;Gi22;…; ;Gin22ð Þ′ be the expression levels
of two independent random samples from normal
populations N μi1; σ i21
 
and N μi2; σ2i2
 
, respectively.
The ST on H01
(i) : μi1 = μi2 assumes variance homogen-
eity (H02
(i) : σi1
2 = σi2
2 ) between the two conditions, and
defines the test statistic as
t^ ¼
1
n1
þ 1n2
 −12
μ^i1−μ^i2ð Þﬃﬃﬃﬃﬃ
σ^ 2p
q ;
where σ^ 2p ¼ n1−1n1þn2−2 σ^
2
i1 þ n2−1n1þn2−2 σ^
2
i2 is the pooled sam-
ple variance estimator of the common variance σ2. If
H03
(i) =H01
(i) ∩H02
(i) is true, then the testing statistic t^ follows
the centralized Student t distribution with (n1 + n2 − 2) de-
grees of freedom t^etn1þn2−2 . It is well known that violat-
ing the assumption of variance homogeneity would result
in type I error inflation or power loss of the ST [17].
The WT, as an adaptation of the ST, is more reliable
when the two-group samples have unequal variances and
unequal sample sizes. The Welch statistic is defined by
dWT ¼ μ^i1−μ^i2ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
σ^ 2i1
n1
þ σ^ 2i2n2
q
This statistic calibrates the impact of potential variance
heterogeneity between two conditions. For a gene with
equal means between two conditions (regardless of variance
heterogeneity), dWT approximately follows a t-distribution
with the following Welch-Satterthwaite degree of freedom:
ν ¼ ðσ^ i1
2
n1
þ σ^ i22n2 Þ2
σ^ i1
4
n21 n1−1ð Þ
þ σ^ i24n22 n2−1ð Þ
  :
To calibrate unequal variances, another alternative is
the MWT [6], which would yield reliable condition-
specific variance estimators for low-replicate experi-
ments. For large-sample experiments, one can perform
Student t test on standardized data (STSD), where the
gene expression levels are divided by condition-specific
sample standard deviations respectively.
Concept of MVDE genes and variance heterogeneity tests
A gene is called to be susceptible if the change in condi-
tion can alter arbitrary aspects of the entire distribution
of its expression level, i.e., mean, variance, kurtosis and/
or even higher-order characteristics. The term MVDE
gene is adopted to describe a gene whose mean and/or
variance in expression level is sensitive to the change in
condition. Formally, a MVDE gene has different means
(μ1 ≠ μ2) and/or variances (σ1
2 ≠ σ2
2) of expression levels
between two conditions. This concept of MVDE genes
goes one step closer to our general concept of a suscep-
tible gene and is more reasonable than the conventional
concept of MDE genes, which confines to differential
mean expression levels only. In gene co-expression net-
works, genes work together and the expression levels are
correlated. Some susceptible genes may also interact
with other susceptible genes and/or environmental fac-
tors. Such correlations and interactions among biological
networks are very common and are major drivers for the
variance heterogeneity of a test susceptible gene. Vari-
ance heterogeneity, to some extent, indicates how a gene
involve in complex networks. Therefore, we argue that
variance heterogeneity should be as equally important as
mean heterogeneity for identifying differentially expressed
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genes. To identify susceptible genes, one crucial step is to
extract summary statistics containing potential informa-
tion about variance heterogeneity, i.e., the p values com-
puted from some appropriate test statistic on the null
hypothesis H02
(i) (variance homogeneity).
For a random gene, if its (transformed) expression
levels follow normal distribution, then the classical two-
sample F-statistic
F^ ¼ σ^ i1
2
σ^ i22
follows the centralized F-distribution with (n1 − 1) and
(n2 − 1) degrees of freedom F^eFn1−1;n2−1
 
since H02
(i) is
true. Under normality setting, the F-test is the most
powerful test for exploiting variance heterogeneity.
Nevertheless, the F-test is very sensitive to the violation
of normality. Therefore, it may claim random genes to
be spuriously significant if their (transformed) expres-
sion levels do not strictly follow normal distributions.
Actually, the two-sample F test is more suitable for test-
ing normality other than variance heterogeneity [13].
As a robust alternative, the Brown-Forsythe statistic is
the F-ratio that stems from applying the ordinary one-
way analysis of variance on the absolute deviations from
the median:
cBF ¼ n1 þ n2−2ð Þ
X2
c¼1nc Zic−Zi
 2
X2
c¼1
Xnc
j¼1 Zijc−Zic
 2 ;
where Zijc ¼ Gijc−~Gic
  , Zic ¼ 1nc
Xnc
j¼1Zijc , Zi ¼ 1n1þn2X2
c¼1
Xnc
j¼1Zijc , and
~Gic ¼ median Gcð Þ . When H02(i) is
true, the distribution of cBF follows approximately the F-
distribution with degrees of freedom 1 and (n1 + n2 − 2).
Another alternative, the Levene test, uses the mean in-
stead of the median:
cLF ¼ n1 þ n2−2ð Þ
X2
c¼1nc Zic−Zi
 2
X2
c¼1
Xnc
j¼1 Zijc−Zic
 2 ;
where Zijc ¼ Gijc−Gic
 ;Zic ¼ 1nc
Xnc
j¼1Zijc;Zi ¼ 1n1þn2X2
c¼1
Xnc
j¼1Zijc and Gic ¼ mean Gcð Þ. If H02
(i) is true, then
cLF follows approximately the F distribution with degrees
of freedom 1 and (n1 + n2 − 2).
For each gene, the optimal test for variance heterogen-
eity depends on the underlying gene expression distribu-
tion. According to Brown and Forsythe’s Monte Carlo
studies [15], the Levene test provided the best power for
symmetric, moderate-tailed distributions; whereas the
Brown-Forsythe test performed best when the under-
lying data followed heavily skewed distributions.
Integrating mean and variance heterogeneities
One most commonly used method to integrate two inde-
pendent pieces of information is Fisher’s linear combin-
ation. For a testing gene, let pWT, pF, pBF, pLF denote the p-
values of the Welch statistic, the F statistic, the Brown-
Forsythe statistic and the Levene statistic, respectively. We
recommend using dIMVT ¼ −2 log pWTð Þ þ log pLFð Þð Þ to
integrate mean and variance heterogeneities. Another two
alternatives are dFWT ¼ −2 log pWTð Þ þ log pFð Þð Þ anddBFWT ¼ −2 log pWTð Þ þ log pBFð Þð Þ . Each of the three
Fisher linear combinations follows approximately the χ2 -
distribution with 4° of freedom, provided that the p-values
of mean heterogeneity tests are independent of the p-
values of variance heterogeneity tests under joint null H03.
Alternative tests for the joint null hypothesis of mean and
variance equalities
To test H03, a framework of separate mean and variance
tests (SMVT) can also be conducted. This framework
applies WT on H01 (mean equality) at nominal level α1
and Levene test on H02 (variance equality) at nominal
level α2, respectively. H03 is rejected if H01 or H02 or
both are rejected. By our proposition on the null inde-
pendence, type I error rate of this framework is given by
α = α1 + α2 − α1α2. It is intractable to choose universal
optimal α1 and α2 for all genes. To control the overall
type I error rate at nominal level α, one typical choice is
setting α1 ¼ α2 ¼ 1−
ﬃﬃﬃ
α
p
. Similar as Fisher’s linear com-
bination, the SMVT gives equal weight to mean hetero-
geneity and variance heterogeneity.
The two-sample LRT is another alternative to test H03,
assuming the (transformed) expression levels follow nor-
mal distributions. Specifically, the LRT statistic is given by
dLRT ¼
n1−1
n1
σ^ 2i1
 n1
2 n2−1
n2
σ^ 2i2
 n2
2
1
n1þn2
Xn1
j¼1 Gij1−μ^
 2 þXn2
j¼1 Gij2−μ^
 2  n1þn22 ;
μ^ ¼ 1n1þn2
Xn1
j¼1Gij1 þ
X
j¼1
n2
Gij2
 
(See the Additional
file 1 for mathematical derivation of the LRT statistic).
Under normal setting with H03, χ^
2
2 ¼ −2 ln dLRT
 
fol-
lows χ2 - distribution with 2° of freedom asymptotically
for large sample sizes.
Results
The null independence between the mean and variance
heterogeneity tests
It’s commonly believed that testing statistics of mean
and variance heterogeneities are dependently distributed,
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even if the data forming them are from an identical nor-
mal population. Actually, this is a widespread misunder-
standing due to the forms of the testing statistics. For
example, both Student’s t-statistic and the F-statistic are
defined in terms of sample variances. In fact, all afore-
said testing statistics of mean heterogeneity are inde-
pendent of all aforesaid testing statistics of variance
heterogeneity under H03. This null independence lays
the foundation of type I error rate control of the integra-
tive heterogeneity tests. Herein, we formally formulate
the finite-sample null independence by the following
proposition.
Proposition: Student t statistic and Welch t statistic are
independent of the F-, Levene and Brown-Forsythe statis-
tics if the finite samples (G1, G2) forming them jointly fol-
low an arbitrary spherically symmetric distribution.
The proposition formulates the finite-sample null in-
dependence under a broader distribution family, includ-
ing normality as a special member (for mathematical
proofs, see Additional file 2: Appendixes A and B). Its
typical members include multivariate Gaussian, Student,
Kotz, exponential power, Laplace distributions with
spherically symmetric variance-covariance matrices [13].
Many researchers are familiar with and usually adopt
normality assumption on (transformed) gene expression
levels. By this proposition, if the normality assumption is
met, the proposed integrative heterogeneity tests can
properly control the type I error rate. However, the nor-
mality assumption is often violated more or less by real-
world gene expression data. Rigorously speaking, no
transformation of gene expression data can assure exact
normality. Therefore, it is necessary and useful to extend
the null independence to broader distribution families,
e.g., spherically symmetric family.
Empirical illustrations of the proposition
First, we generated 100,000 replicates of two-group sam-
ples from the standard normal distribution with sample
size n1 = n2 = 40. As anticipated by the proposition, the
vast majority of replicate-specific pairs of Welch t statis-
tic dWT
 
and Levene statistic cLF
 
randomly concen-
trates around (0, 1) (Fig. 1a) and so do the replicate-
specific Welch t statistic and F statistic pairs (Fig. 1b).
Under this simulation design, Welch t and Student t sta-
tistics dWT ; t^
 
appeared equivalent (Fig. 1c). The cor-
relation between Levene statistic cLF
 
and Brown-
Forsythe statistic cBF
 
turned to be 0.9894 (Fig. 1d).
The scatterplots of t^ ;cLF
 
, t^ ;cBF
 
, and t^ ; F^
 
are
qualitatively the same as those of dWT ;cLF
 
(Results
not shown here). Under the normality setting with
smaller sample sizes, we also obtained the corresponding
figures for some other sample sizes (Additional file 2:
Figure S1.1–Figure S1.3, Appendix C), which revealed
very similar patterns to Fig. 1. Standard multi-variate
normal distribution is a typical member in the family of
spherically symmetric distributions. These simulation re-
sults illustrate the null independence within the family
of all spherically symmetric distributions.
As explorations outside of the spherically symmetric
family, we performed comprehensive simulations by
generating the data from the standard Laplace distribu-
tion. Univariate Laplace distribution is a typical member
of the family of symmetric distributions. However, the
joint distribution of independent univariate Laplace vari-
ables is outside of the spherically symmetric distribution
family. Under the standard Laplace setting, we obtained
the corresponding scatterplots and observed similar pat-
terns of the joint distributions of the mean and variance
test statistics (Additional file 2: Figure S2.1–Figure S2.4,
Appendix C). These empirical results illustrate the ro-
bustness of the null independence between mean and
variance tests for the data from the family of symmetric
distributions.
Type I error rates control of the competitors
Under normality setting. With extremely small samples,
none of the eight competitors could properly control
type I error rates (Fig. 2a). The LRT and the STSD se-
verely inflated type I error rates. The IMVT and the
SMVT appeared equally anti-conservative; both were
much less anti-conservative than the LRT and the STSD.
The MWT performed the best to control type I error
rates; it was slightly conservative. The WT and the FWT
appeared equally conservative; both were clearly more
conservative than the MWT. The BFWT appeared se-
verely conservative. The LRT inflated the type I error
rates because the χ2
2 distribution could not well approxi-
mate the exact distribution of the LRT statistic. The
anti-conservative of the STSD stemmed from the vari-
ability of condition-specific data standardization. Specif-
ically, sample standard deviations of small samples could
not precisely estimate the standard deviation. The con-
servativeness of the BFWT stemmed from the well-
known conservativeness of the Brown-Forsythe test [18,
19]. For larger sample sizes (Fig. 2b-d), the LRT, the
STSD, the SMVT and the IMVT appeared less anti-
conservative, and the MWT, the WT, the FWT and the
BFWT became less conservative. When sample sizes
reached 40, the IMVT and the SMVT as well as the WT,
the MWT and the FWT properly controlled the Type I
error rates (Fig. 2d).
Under the Laplace setting, the LRT and the FWT ap-
peared severely anti-conservative (Fig. 3a-d). Their infla-
tions in type I error rate appeared even severer as the
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samples increased. The LRT had inflated type I error
rates because it was derived from normality assumption
of gene expression levels. The FWT had inflated type I
error rates because the F test statistic is very sensitive to
the non-normality of the samples [13]. The other tests
displayed similar patterns to those under normality set-
ting. For extremely small sample sizes, the STSD, the
IMVT and the SMVT appeared successively less anti-
conservative; whereas the MWT, the WT and the
BFWT appeared successively more conservative (Fig. 3a).
Their magnitudes of inflations and deflations in type I
error rate appeared to vanish as the sample sizes in-
creased (Fig. 3b-d).
Empirical power comparisons under normality setting
and non-normality setting
For power comparisons, we investigated three kinds of
scenarios under both normality setting and Laplace set-
ting: (1) unequal mean and equal variance, (2) equal
mean and unequal variance and, (3) unequal mean and
unequal variance. For sample sizes as large as n1 = n2 =
40, the proposed and existent tests well controlled type I
error rates under normality and Laplace setting. And the
sample size is very close to those of the gene expression
files of Pan et al. [16]. We thus presented here the power
comparisons with the sample sizes n1 = n2 = 40.
Under normality setting, we simulated independently
10,000 replicates of n1 = 40 data points from normal dis-
tribution N 0; 1ð Þ and n2 = 40 data points from N r; 1þ sð Þ2
 
for each (r, s) pair. Herein, the parameters r and s repre-
sent the magnitudes of mean and variance heterogene-
ities, respectively. When s ≠ 0, the IMVT and the FWT
displayed the highest powers, followed by the SMVT;
and all the three joint heterogeneity tests outperformed
the three mean heterogeneity tests, i.e., the WT, the
MWT and the STSD (Fig. 4a-b). The power gains of the
joint heterogeneity tests over the mean heterogeneity
tests appeared especially noteworthy when s ≠ 0 and r =
0 (Fig. 4b). The joint heterogeneity tests did not display
severe power losses even for the theoretical scenarios fa-
voring the mean tests (Fig. 4c). In addition, the FWT
slightly outperformed the IMVT because the F test
statistic is the optimal test statistic for variance het-
erogeneity under normality setting. Here, we did not
Fig. 1 Null joint distributions of the test statistics on mean and variance heterogeneities under normality setting. Each panels displays 100,000
pairs of the specified test statistics, which were computed from 100,000 replicates of two-group samples of sizes (n1 = n2 = 40) from the standard
normal distribution. Panel a shows the null independence between Welch t statistic and Levene statistic. Panel b shows the null independence
between Welch t-statistic and F-statistic. Panel c shows the equivalence between Welch t statistic and Student t statistic. Panel d shows the high
correlation between Levene test statistic and Brown-Forsythe statistic
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compare the powers of the LRT and the BFWT since
they could not control type I error rates.
Under Laplace setting, we simulated independently
10,000 replicates of n1 = 40 data points from standard
Laplace distribution Laplace (0, 1) and n2 = 40 data
points from Laplace (r, (1 + s)2) for each (r,s) pair. Again,
the parameters r and s represent the magnitudes of
mean and variance heterogeneities, respectively. Under
the Laplace setting, we observed qualitatively the same
patterns as those under the normality setting. When s ≠
0, the IMVT outperformed the SMVT; and both the
joint heterogeneity tests outperformed the three mean
heterogeneity tests, i.e., the WT, the MWT and the
STSD (Fig. 5a-b). The power gains of the joint hetero-
geneity tests over the mean heterogeneity tests appeared
especially noteworthy when s ≠ 0 and r = 0 (Fig. 5b). The
joint heterogeneity tests did not display severe power
losses even for the theoretical scenarios favoring the
mean heterogeneity tests (Fig. 5c). Here, we did not
compare the powers of the LRT, the FWT and the
BFWT since they could not control type I error rates
under non-normality setting.
These results formally demonstrate the importance of
integrating informative variance heterogeneity. In gen-
eral, the power gains of the IMVT over its competitors
are solid. For the scenarios of mean heterogeneity only,
the IMVT would have small power losses. All in all, the
IMVT displayed valuable merits over its competitors. At
least, the IMVT is an admissible procedure. It should be
useful to improve the power to identify susceptible genes
involved in co-expression networks. By its robustness to
non-normality data, we recommend the IMVT as a
powerful alternative to exploit microarray profiles.
Re-analyzing the gene expression profiles of peripheral
circulating B Lymphocytes
Pan et al. [16] compared the gene expressions profiles of
peripheral circulating B cells between 39 smoking and
40 non-smoking healthy US white women. Using MAS5
software, they normalized the expression levels of 7215
selected probes out of all the 22,283 experiment-wide
probes. They applied traditional t tests to the normalized
expression levels and report 125 promising DE genes.
The authors justified why they did not adjust for meno-
pausal status and age. However, they neglected the latent
background data structure. Using the MAS5 software,
we normalized the raw expression levels of all the 22,283
experiment-wide gene probes. For the normalized data,
we computed the probe specific test statistics and p
values of five competitors. The genomic inflation factors
[20] of these heterogeneity tests would be close to 1 if
they could properly control type I error rates. However,
Fig. 2 Comparison of false positive rates of eight methods under standard normality setting. Each panel was computed from 100,000 replicates
of two-group samples with the specified samples sizes simulated from N 0; 1ð Þ. At each significance level, the false positive rate of each method
was estimated by the empirical proportion that the method rejected the dual null hypothesis H03. The gray belt is the 95% concentration band
of the false positive rates of a typical test that can properly control false positive rates at given nominal significance levels. a n1=n2=5, b
n1=n2=10, c n1=n2=20, d n1=n2=40
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all the tests displayed huge genomic inflation factors, es-
pecially the STSD (Fig. 6). All the Q-Q plots climbed
quickly above the upper limit of the 95% concentration
band (the gray band). The severe genomic inflations in-
dicated that some major latent factors would confound
all the competitors. Thus, the t tests performed by Pan
et al. [16] would be confounded since they did not adjust
for any background factors.
To reveal latent data structure, we first conducted
PCA of the MAS5 normalized expression levels of all
Fig. 4 Power comparison of six methods under two-condition normality setting. In each panel, for each specific (r, s) pair, powers of the six
methods were computed from 100,000 replicates of two-group samples with samples sizes (40 vs. 40) simulated from N 0; 1ð Þ and N
r; 1þ sð Þ2 , respectively. At each (r, s) pair, the power of each method was estimated by the empirical proportion that the method rejected the
dual null hypothesis H03 at significance level 0.05. For the SMVT, both the significance level of Welch test and that of the Levene test were set to
be 1−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1−0:05
p
to control overall type I error rate at 0.05. a Dual heterogeneity, b Variance heterogeneity, c Mean heterogeneity
Fig. 3 Comparison of false positive rates of eight methods under standard Laplace setting. Each panel was computed from 100,000 replicates of
two-group samples with the specified samples sizes simulated from ℒaplace(0, 1). At each significance level, the false positive rate of each
method was estimated by the empirical proportion that the method rejected the dual null hypothesis H03. The gray belt is the 95% concentration
band of the false positive rates of a typical test that can properly control false positive rates at given nominal significance levels. a n1=n2=5, b
n1=n2=10, c n1=n2=20, d n1=n2=40
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the 22,283 experiment-wide gene probes (Fig. 7, Add-
itional file 3: Table S1). PC1 was the unique major PC,
accounting for 98.24% of the total variation (Fig. 7a).
PC2 merely accounted for 0.32% of total variation. Neither
PC1 nor PC2 displayed mean heterogeneity or variance
heterogeneity between the smokers and nonsmokers
(Fig. 7b). PC4 displayed strikingly significant mean hetero-
geneity (pWT = 1.91 × 10
− 15), even if it only accounted
for 0.13% of the total variation. PC6 displayed very signifi-
cant variance heterogeneity (pLF = 3.2 × 10
− 4) even if it
accounted for 0.07% of the total variation only. PC4 and
PC6 distinguished the smokers and the nonsmokers
(Fig. 7c). Additional file 3: Table S1 listed the first 2 and
all the global PCs with significant mean and/or variance
heterogeneities. These significant global PCs did not
distinguish informative heterogeneities and impediment
heterogeneities. They were so significant in that they
would account for portions of informative mean and
variance heterogeneities of DE genes in addition to back-
ground heterogeneities. As shown in Fig. 8, naively adjust-
ing for the significant global PCs of all gene probes would
result in severe power loss (genomic deflation).
To prevent false positives and false negatives, we se-
lected 13,415 ‘robust’ gene probes to capture the back-
ground data structure. The spirit here is similar to the
use of control genes to account for unwanted variation
[17]. None of the robust gene probes displayed mean
heterogeneity or variance heterogeneity, before and after
calibrating the significant background PCs, age and
menopausal status. We conducted PCA of the MAS5
normalized data of the ‘robust’ gene probes (Fig. 9,
Additional file 3: Table S2). PC1 alone accounted for
98.35% of the total variation and was the unique major
PC. PC2 merely accounted for 0.37% of total variation
(Fig. 9a). Neither PC1 nor PC2 displayed mean heterogen-
eity or variance heterogeneity (Fig. 9b). PC14 displayed
the most significant mean heterogeneity (pWT = 0.0036),
even if it only accounted for 0.03% of the total variation.
PC28 displayed the most significant variance heterogen-
eity (pLF = 0.0069) even if it only accounted for 0.01% of
the total variation. PC14 and PC28 displayed clear stratifi-
cation of the smokers and the nonsmokers (Fig. 9c). In
addition, Additional file 3: Table S2 listed the first 2 and
all the background PCs with significant mean and/or vari-
ance heterogeneities. After adjusting for these significant
Fig. 5 Power comparison of six methods under two-condition Laplace setting. In each panel, for each specific (r, s) pair, powers of the six
methods were computed from 100,000 replicates of two-group samples with samples sizes (40 vs. 40) simulated from ℒaplace(0, 1) and
ℒaplace(r, (1 + s)2), respectively. At each (r, s) pair, the power of each method was estimated by the empirical proportion that the method
rejected the dual null hypothesis H03 at significance level 0.05. For the SMVT, both the significance level of Welch test and that of the Levene
test were set to be 1−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1−0:05
p
to control overall type I error rate at 0.05. a Dual heterogeneity, b Variance heterogeneity, c Mean heterogeneity
Fig. 6 Q-Q plots of the five competitors without adjusting for latent
data structure and covariates. Using the MAS5, we normalized the raw
expression data of the 22,283 gene probes on the 39 smokers and 40
nonsmokers. We then compute gene probe specific statistics and p
values of the tests statistics based on the MAS5 normalized data. The
inflation factors of all the tests appeared unreasonably huge, especially
that of the STSD. All the curves clearly appeared above the gray band
(95% concentration band). The striking inflations implied that some
latent factors severely confounded the competitors
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background PCs, age and menopausal status, the Q-Q
plots of all the five tests climbed above the diagonal
(Fig. 10). Especially, the Q-Q plot of the IMVT climbed
above the upper limit of the 95% concentration band. All
the five tests displayed reasonable inflation factors. The
mild inflation might be due to weak differentials or re-
sidual correlations between DE genes.
Applied to the calibrated expressions, our IMVT
identified CUL7, RBMY1J, RDH5 and SOCS3 to be
experiment-wide significant (Table 1), i.e., pIMVT < 0.05/
22283 = 2.24 × 10− 6. The STSD only identified CUL7 as
experiment-wide significant gene; while the WT and the
MWT failed to identify any experiment-wide significant
genes. The experiment-wide minimum p value of the WT
and the MWT turned to be 2.73 × 10− 5, much larger than
2.24 × 10− 6. The SMVT failed to identify any gene to be
experiment-wide significant. At DDX3X, the WT reached
the experiment-wide minimum pWT = 3.10 × 10
− 5. For
SMVT, both pWT and pLF must be smaller than
threshold 1−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1−0:05=22283
p ¼ 1:12 10−6 to control overall
experiment-wide type I error rate at 0.05. Therefore, our
analysis of the real data provided solid evidence for the su-
periority of the IMVT over the SMVT. Without adjusting
for the data structure and covariates, Pan et al. [16] did
not report any of the four genes although their results
were severely inflated. SOCS3 was reported to be related
to tobacco smoking by independent studies [21–24]. Per
the database of cancer gene networks (TCNG; http://
tcng.hgc.jp/index.html), CUL7 [25–27], RBMY1J [25, 27]
and RDH5 [25–30] were reported to involve in func-
tion gene networks related to smoking. All the four
experiment-wide significant gene probes displayed
both mean and variance heterogeneities (Fig. 11). In
addition to the four experiment-wide significant
genes, our IMVT identified 16 genes that testified to
be involved in functional networks by Pan et al. [16]
at nominal level 0.05 (Table 2). For a test gene within
a network of functional genes, incorporating its
Fig. 7 Global data structure of all the experiment-wide gene expression levels. Using MAS5, we normalized the raw expression levels of the
22,283 experiment-wide gene probes and computed the PCs of all the normalized expression levels. PC1 alone accounted for 98.24% of the total
variation and was the unique major PC. PC2 merely accounted for 0.32% of total variation. Neither PC1 nor PC2 displayed mean heterogeneity or
variance heterogeneity. PC4 displayed strikingly significant mean heterogeneity (pWT = 1.91 × 10
− 15), even if it only accounted for 0.13% of the
total variation. PC6 displayed very significant variance heterogeneity (pLF = 3.18 × 10
− 4) even if it accounted for 0.07% of the total variation only.
PC4 and PC6 clearly distinguished the smokers and the nonsmokers. a Variation proportions, b PC1 and PC2, c PC4 and PC6
Fig. 8 Deflations due to the over adjustment of the experiment-wide
data structure. Among all the 79 global PCs, only PC4 displayed
significant mean heterogeneity (pWT =4.49E-15). PC6, 9, 14, 28,
38, 49 and 78 displayed variance heterogeneity (pLF ranged from
3.18E-4 to 0.0419). After adjusting for the significant global PCs, age
and menopausal status, the Q-Q plots of all the five competitors
displayed severe deflations. All the genomic inflation factors turned
out to be much smaller than 1. The Q-Q plots of the four mean
heterogeneity tests fell below the diagonal, where those of the WT
and the MWT fell below the lower limit of the 95% concentration
band. Global PCs did not distinguish informative heterogeneities and
impediment heterogeneities. The significant global PCs would account
for big portions of informative mean and variance heterogeneities due
to DE genes. Therefore, adjusting for the significant PCs of all the
experiment-wide gene probes would reduce statistical powers
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informative variance heterogeneity proved one effect-
ive way to exploit extra information as provided by
the other function genes in the same network.
The false discovery rate (FDR) would be a more appro-
priate error rate to control than the familywise error rate
in microarray studies; and several standard FDR control-
ling procedures have been widely practiced [31–34].
We did identify more promising gene probes when
applying the most widely used FDR controlling pro-
cedure to the p values generated by our IMVT. For
example, controlling FDR at the stringent level 0.05,
our IMVT identified 24 out of the experiment-wide
22,283 gene probes. Controlling FDR at the same
level, the STSD only identified CUL7, while both the
WT and the MWT missed all promising gene probes
(Additional file 3: Table S3). Controlling FDR at level
0.1, our IMVT claimed 55 gene probes, while all the
three mean heterogeneity tests discovered no add-
itional gene probes. These results have well demon-
strated noteworthy gains of explicitly exploiting
informative variance heterogeneity. Without adjusting
for background data structure, Pant et al. claimed 125
gene probes with local FDRs < 0.05. Their published
list of promising gene probes displays huge discrepan-
cies to ours. Such discrepancies stemmed from the
severe inflation in their t tests (Fig. 6). Judiciously
Fig. 9 Background data structure of the expression levels of robust gene probes. From the MAS5 normalized data, we selected 13,415 robust
gene probes and conducted background PCA. PC1 alone accounted for 98.35% of the total variation and was the unique major PC. PC2 merely
accounted for 0.37% of total variation. Neither PC1 nor PC2 displayed mean heterogeneity or variance heterogeneity. PC14 displayed significant
mean heterogeneity (pWT = 0.0036), even if it only accounted for 0.03% of the total variation. PC28 displayed significant variance heterogeneity
(pLF = 0.0069) even if it accounted for 0.01% of the total variation only. PC14 and PC28 displayed clear stratification of the smokers and the
nonsmokers. a Variation proportions, b PC1 and PC2, c PC14 and PC28
Fig. 10 Q-Q plots of the five competitors after adjusting for
background data structure and covariates. Among all the 79
background PCs, PC14, PC25, PC12, PC16, and PC18 displayed
significant mean heterogeneity (pWT ranged from 0.0036 to 0.0149).
PC28, PC29 and PC30 displayed variance heterogeneity (pLF ranged
from 0.0069 to 0.0208). After adjusting for these significant
background PCs, age and menopausal status, the Q-Q plots of all
the five tests climbed above the diagonal. Especially, the Q-Q plot of
the IMVT climbed above the upper limit of the 95% concentration
band. All the tests displayed reasonable inflation factors. The mild
inflation could be due to weak differentials or residual correlations
between DE genes. Adjusting for significant background PCs was
necessary to prevent false positives and false negatives
Table 1 Experiment-wide significant discoveries by the IMVTa
AffyID Gene IMVT STSD MWT WT
203558_at CUL7 1.12E-07 1.55E-06 0.0034 0.0024
208307_at RBMY1J 3.82E-07 0.0051 0.0422 0.0398
210106_at RDH5 1.56E-06 0.0059 0.0295 0.0302
206359_at SOCS3 2.22E-06 0.0014 0.0081 0.0078
aAll the probe-specific pIMVT values reported here are smaller than 0.05/22,283 =
2.2438 × 10-6. The STSD identified CUL7 with much weaker evidence while the
WT and MWT did not identify any gene probe to be experiment-wide significant
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calibrating background data structure is thus neces-
sary for accurately prioritizing gene probes.
Discussion
Integrating informative variance heterogeneity holds tre-
mendous potential to identify novel genes which involve
in gene-gene co-expression and interaction networks.
Susceptible genes can co-express as indicated by gene-
gene correlations [7, 8]. Genes can interact with each
other and/or interact with environmental factors. For ex-
ample, Pan et al. [16] reported 33 gene probes to involve
in constructed functional network. Among which, inde-
pendent studies reported MYH11, HOXB1, GIT2,
VCAM1, CCR1, IQGAP1, PDPK1, HBA1 HBA2, SON, and
CPM to involve in networks related to lung cancer and
smoking [25–30]. Within a complex network, the distri-
bution change in the expression level of a single suscep-
tible gene cannot determined by its mean heterogeneity
completely. Higher-order heterogeneities can provide
extra valuable information for the distribution change.
This is why the IMVT led to smaller p values than did ex-
istent mean heterogeneity tests in our data analyses. In
conclusion, integrating informative variance heterogeneity
proved an effective step to better capture the latent infor-
mation conveyed by the co-expression and interaction
networks of susceptible genes. It represents one efficient
way to extract the inherent higher-order information as
induced by complex networks of multiple biomarkers.
Fig. 11 Boxplots of four experiment-wide significant gene probes. After calibrating the background data structure, no gene probes appeared
experiment-wide significant mean heterogeneity. All of these four genes displayed certain significance of mean heterogeneity and displayed
nearly experiment-wide significant variance heterogeneity. Integrating variance heterogeneity and mean heterogeneity led us to identify these
four gene probes to be experiment-wide significant
Table 2 The overlap of the discoveries of our IMVT and the
genes which were testified to be involved in functional networks
AffyID Gene Adjusted MAS5* MAS5**
IMVT STSD MWT WT ST
201085_s_at SON 0.0075 0.0021 0.0021 0.0023 2.15E-14
203868_s_at VCAM1 0.0030 0.0004 0.0005 0.0005 2.03E-07
204524_at PDPK1 0.0470 0.0328 0.0337 0.0346 7.12E-11
204600_at EPHB3 0.0178 0.0165 0.0207 0.0213 2.83E-04
205008_s_at CIB2 0.0387 0.0122 0.0117 0.0123 1.25E-06
205099_s_at CCR1 0.0058 0.0104 0.0160 0.0165 6.55E-11
206788_s_at CBFB 0.0003 4.34E-05 4.28E-05 4.71E-05 <1.00E-17
207961_x_at MYH11 0.0001 0.0139 0.0370 0.0383 8.11E-06
208164_s_at IL9R 0.0311 0.0074 0.0072 0.0077 4.05E-05
209876_at GIT2 0.0024 0.0040 0.0053 0.0057 1.20E-08
211197_s_at ICOSLG 0.0448 0.0423 0.0479 0.0487 3.28E-05
211699_x_at HBA1 0.0455 0.3238 0.3632 0.3667 2.70E-03
212514_x_at DDX3X 0.0002 3.06E-05 2.73E-05 3.10E-05 2.22E-16
213446_s_at IQGAP1 0.0082 0.0306 0.0400 0.0413 8.37E-10
217557_s_at CPM 0.0347 0.2422 0.2678 0.2701 1.61E-03
219599_at EIF4B 0.0006 0.0005 0.0018 0.0019 5.80E-14
*These raw p values of the heterogeneity tests based on the calibrated
expression levels after adjusting for age, menopausal status, and the
background structure
*These raw p values of Student t tests in Pan et al. [16] based on the MAS5
normalized data before adjusting for any of age, menopausal status, and the
background structure
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The IMVT aims to identify genes whose expression
distributions are susceptible to the change in condition.
It does not distinguish informative variance heterogen-
eity from mean heterogeneity. Before applying the
IMVT, background data structures must be calibrated to
prevent false positive discoveries and power loss. Data
structure can be a major confounder for differential ana-
lyses, as illustrated by our reanalysis of Pan et al.’s gene
profiles [16]. The discrepancy between Pan et al.’s and
our discoveries showed the severe confounding impact
of the global data structure on differential analyses. In a
judicious data calibration, the data structure should be
computed from random genes to prevent power loss due
to over adjustment.
The IMVT and the SMVT as well, inherit the advan-
tages and disadvantages of the Levene test and the WT.
The Levene test is a robust non-parametric method. The
exact distribution of the Levene statistic is intractable,
and thus its p-value must be evaluated by its asymptotic
distribution. The condition-specific variance estimators
in the Welch statistic could not be accurate for small
samples. Thus, the current IMVT is suitable for large
samples other than small samples. By our simulation
studies and the work of Demissie et al. [6], the MWT
could outperform the WT, especially for extremely small
sample sizes. Novel parametric methods, i.e., the LRT,
are needed to mine expression files of low-replicate ex-
periments. However, the test statistic and its exact null
distribution of a parametric test statistic depend on the
exact distributions of the (transformed/calibrated) gene
expression levels. It is intractable to learn the exact dis-
tributions of gene expressions from small samples.
Model miss-specifications can mess up differential
analyses, as showed by the severe inflations in type I
error rate of the normality-based LRT under the La-
place settings. The development of effective small-
sample tests requires further formal efforts. In
addition, appropriate adjustment of background data
structures and other hidden confounders are important
for the success of effectively integrating informative
variance heterogeneity instead of spurious variance
heterogeneity.
Lastly, we acknowledge that there is no need to con-
sider variance heterogeneity in case the distribution of
the expression measure of a gene can be determined by
a single parameter, i.e., its mean. In such a case, the
IMVT can be less powerful than the Welch test. How-
ever, single-parameter distribution cannot well fit real-
world expression levels in general. Due to the high com-
plexity of gene networks, the expression distribution of a
gene cannot be solely determined by its mean. Distribu-
tion heterogeneity is a much bigger umbrella than mean
heterogeneity. The proposed IMVT merely made one
step further from traditional mean heterogeneity tests.
High-order heterogeneities are quite common and re-
quire particular exploitation methods.
Conclusions
In this paper, we put forth the concept of MVDE gene and
mathematically proved the null independence between
mean heterogeneity tests and variance heterogeneity tests.
From existent mean heterogeneity tests, we made one step
further to identify susceptible genes, whose expression
distributions alter with the change in experimental condi-
tion. We formally justified this conceptual shift from
MDE to MVDE. Specifically, we developed the IMVT as a
robust, powerful procedure to integrate informative mean
and variance heterogeneities. By extensive simulations
under normality and non-normality settings and con-
ducted intensive real-world data analysis, the IMVT out-
performed some existent mean heterogeneity tests (e.g.,
the WT, the MWT, the STSD) and some conventional
joint heterogeneity tests (e.g., the LRT, the SMVT).
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